Skip to main content

Table 4 Results of linear regression analysis of GGT levels and various cardiovascular risk scores

From: Gamma glutamyl transferases in association with cardiovascular risk scores in non-diabetic hypertensive Cameroonians: preliminary data from HYRICCA study

Variables

Model 1

Model 2

Model 3

Framingham score (2008)

0.64 (− 0.06; 1.56)

p = 0.42

0.075 (− 0.013; 0.16)

p = 0.09

0.035 (− 0.048; 0.11)

p = 0.4

ASCVD/AHA (2013)

0.048 (− 0.097; 0.19)

p = 0.51

0.1 (− 0.025; 0.23)

p = 0.11

0.067 (− 0.06; 0.19)

p = 0.32

Reynolds score

0.006 (− 0.17; 0.19)

p = 0.84

0.016 (− 0.16; 0.19)

p = 0.17

− 0.038 (− 0.22; 0.14)

p = 0.68

WHO risk score

− 0.007 (− 0.089; 0.076)

p = 0.86

0.042 (− 0.013; 0.09)

p = 0.13

0.03 (− 0.029; 0.089)

p = 0.31

EuroScore 2003

− 0.016 (− 0.06; 0.028)

p = 0.47

0.009 (− 0.027; 0.045)

p = 0.64

0.004 (− 0.035; 0.042)

p = 0.85

Plasma atherogenic index

0.004 (0.001; 0.007)

p = 0.021

0.004 (0.001; 0.007)

p = 0.017

0.001 (− 0.001; 0.001)

p = 0.37

  1. Model 1: unadjusted; Model 2: adjuster for age and gender; Model 3: Model 2 + adjustment for HDL, LDL, triglycerides, ALT, WC, hsCRP; Non standardized beta coefficient and its 95% confidence interval